← Back to Search

Behavioural Intervention

Vibrotactile Stimulation for Parkinson's Disease

N/A

Recruiting

Led By Phan Luu, PhD

Research Sponsored by Synergic Medical Technologies, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 2 months, 4 months

Awards & highlights

Study Summary

This trial is testing a non-invasive, vibrotactile stimulation approach to treat motor symptoms of Parkinson's Disease, an alternative to drugs and deep brain stimulation.

Who is the study for?

This trial is for individuals aged 45-90 with moderate stage idiopathic Parkinson's Disease (PD), who can undergo EEG procedures. It's not open to patients on dopamine agonist medications if they show compulsive behaviors.Check my eligibility

What is being tested?

The study tests a non-invasive vibrotactile stimulation called coordinated reset (CR) against a sham procedure, aiming to improve motor symptoms in PD by disrupting the disease's pathophysiological mechanisms.See study design

What are the potential side effects?

As this is a non-invasive treatment involving sensory stimulation, side effects are expected to be minimal but may include discomfort or skin irritation at the site of vibration.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 2 months, 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 2 months, 4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 months, 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Movement Disorder Society - Change in Universal Parkinson Disease Rating Scale (MDS-UPDRS)

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Active vibrotactile coordinated resetActive Control1 Intervention

mechanical vibrotactile stimulation to the fingers in a defined pattern

Group II: Sham vibrotactile coordinated resetPlacebo Group1 Intervention

mechanical vibrotactile stimulation to the fingers in a defined pattern

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Synergic Medical Technologies, Inc.Lead Sponsor

2 Previous Clinical Trials

66 Total Patients Enrolled

Phan Luu, PhDPrincipal InvestigatorSynergic Medical Technologies, Inc.

Media Library

Active Vibrotactile Coordinated Reset (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05830110 — N/A

Parkinson's Disease Research Study Groups: Active vibrotactile coordinated reset, Sham vibrotactile coordinated reset

Parkinson's Disease Clinical Trial 2023: Active Vibrotactile Coordinated Reset Highlights & Side Effects. Trial Name: NCT05830110 — N/A

Active Vibrotactile Coordinated Reset (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05830110 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the current research project open to individuals over eighty years of age?

"According to the trial's guidelines, those who wish to take part must fall between 45 and 90 years old."

Answered by AI

Is this medical experiment actively seeking new participants?

"Affirmative, the information on clinicaltrials.gov attests to this trial's current recruitment status. This research opportunity was first made available June 1st 2019 and has been recently edited April 25th 2023. The study is searching for 30 individuals across a single site."

Answered by AI

How many test subjects are included in this clinical research?

"Yes, clinicaltrials.gov conveys that this medical examination is presently enrolling individuals. The trial initially went live on June 1st 2019 and has been most recently updated on April 25th 2023. A total of 30 participants are required for the single-site study."

Answered by AI

Am I eligible to take part in this clinical trial?

"To partake in this research, potential participants must have been diagnosed with Parkinson's disease and aged between 45 to 90 years old. Approximately 30 individuals are required for the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease

2019. "Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05830110.